v3.26.1
Condensed Consolidated Interim Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating activities:        
Net loss from continuing operations $ (11,375) $ (5,053) $ (17,082) $ (10,348)
Adjustments to reconcile net income (loss) to net cash used in continuing operating activities:        
Depreciation and amortization 255 219 467 397
Stock-based compensation expense 110 126 196 304
Unrealized foreign exchange loss (gain) 1,693 (4,224) 2,700 (5,427)
Deferred income tax (recovery) 0 (6) 0 (9)
Loss from investments accounted for by the equity method 1,283 3,686 2,664 7,570
Interest on long-term debt 23 23 47 45
Inventory write-downs 54 140 54 110
Bad debt expense 14 0 2 0
Change in fair value of warrant liabilities (note 12) 1,496 0 1,496 0
Financing transaction costs 1,085 0 1,085 0
Warranty provision (124) 0 (124) 0
Changes in working capital 923 (533) 594 (6,869)
Net cash used in operating activities from continuing operations (4,563) (5,622) (7,901) (14,227)
Net cash (used in) provided by operating activities from discontinued operations 0 (582) 0 3,125
Investing activities:        
Purchase of property, plant and equipment (note 9) (48) (822) (480) (1,395)
Proceeds from holdback receivable (note 6) 0 0 5,844 10,450
Capital contributions to investments accounted for by the equity method (note 8) (3,512) (4,185) (6,364) (8,871)
Net cash (used in) provided by investing activities from continuing operations (3,560) (5,007) (1,000) 184
Net cash used in investing activities from discontinued operations 0 (460) 0 (2,947)
Financing activities:        
Repayments of operating lines of credit and long-term facilities (1,000) (1,000) (2,000) (2,000)
Drawings on operating lines of credit and long-term facilities 0 0 0
Proceeds from issuance of common share, warrants, and pre-funded warrants 10,000 0 10,000 0
Payment of shares and warrants issuance costs (700) 0 (700) 0
Net cash (used in) provided by financing activities from continuing operations 8,300 (1,000) 7,300 (2,000)
Net cash used in financing activities from discontinued operations 0 (3,176) 0 (6,094)
Effect of foreign exchange on cash and cash equivalents (734) 4,593 (1,611) 5,696
Net decrease in cash and cash equivalents (557) (11,254) (3,212) (16,263)
Cash and cash equivalents, beginning of period (including restricted cash) 24,503 32,637 27,158 37,646
Cash and cash equivalents, end of period (including restricted cash) 23,946 21,383 23,946 21,383
Less: cash and cash equivalents from discontinued operations, end of period (including restricted cash) 0 15,319 0 15,319
Cash and cash equivalents from continuing operations, end of period (including restricted cash) 23,946 6,064 23,946 6,064
Supplementary information        
Interest paid 45 536 111 1,182
Taxes paid, net of refunds 31 1,050 87 1,406
Changes in working capital:        
Accounts receivable (393) (8,160) 505 (8,324)
Inventories 159 5,879 197 3,770
Prepaid expenses 498 600 524 920
Accounts payable and accrued liabilities 647 1,056 (675) (3,240)
Warranty liability 12 92 43 5
Changes in working capital $ 923 $ (533) $ 594 $ (6,869)